Search Results
Results found for "Novo Nordisk Foundation"
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck Foundation Fellowship, and Novo Nordisk Foundation Ascending Investigator awards.
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
Nordisk, and into biotech at InterAx — where the next challenge is using functional fingerprints to After running her own academic group in Graz, she spent six and a half years at Novo Nordisk in early Nordisk, putting it in an animal, and watching the effect come back exactly as predicted. After working in the US and at the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech in Switzerland as their Chief Scientific Officer.
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
Jacek Mokrosiński "Jacek is a Senior Scientist at Novo Nordisk specializing in molecular pharmacology Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US Jacek shared his experience of working with Piketa and how he found a job in Seda's lab at Cambridge,
- Dr. GPCR Board | Dr. GPCR Ecosystem
Berchiche is the founder of Dr. My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
A pharmacologist by training, she spent more than six years in early R&D at Novo Nordisk before turning
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
GPCR Foundry: Accelerate GPCR Drug Discovery Move from idea to insight—faster, smarter, and with confidence full course library, live masterclasses, and community — so your team builds from the same expert-led foundation discovery-stage GPCR work Our Partners Join these innovative organizations already benefiting from the DrGPCR Foundry Wherever you are in your discovery journey, the Foundry helps GPCR biotech companies move faster and
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
has led to a series of high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research with a role as co-founder and Chief Scientific Officer.
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off Eddy Sotelo’s group at CIQUS as a postdoctoral researcher, where the scientific foundations of Celtarys Since co-founding the company in 2021, she has led all scientific activities, from proprietary technology
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
That discovery became the foundation of a career built on the data most pharmacologists generate but About the Guest Sam Hoare is the founder of Pharmechanics , a pharmacology data analysis consultancy. kinetics: quantifying the time dimension of GPCR pharmacology Allosteric modulation and the mathematical foundations What he found was that clients arriving with a data problem are rarely arriving with just a data problem Before founding Pharmechanics in 2016, Dr.
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator
- Tanishka S. Saraf | Dr. GPCR Ecosystem
Saraf on the web FRAXA Research Foundation Google Scholar ResearchGate LinkedIn Dr.
- Steve McCloskey | Dr. GPCR Ecosystem
During his time at UC San Diego Steve worked directly with the founding Chair of the Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center After graduating from UCSD he founded Nanome Inc to build Virtual Reality solutions for Scientists and
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
across the full scope of GPCR science Sessions span the entire landscape of GPCR pharmacology, from foundational Quantitative Approaches Innovation & Strategic Application Innovation & Strategic Application Pharmacology Foundations The recordings are the foundation — the live sessions are where you go further.
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
She is a National Heart Foundation of Australia Future Leader Fellow and runs a laboratory of 7 Ph.D.
- Dr. Randy Hall | Dr. GPCR Ecosystem
Keck Foundation, and the John J. Abel Award from ASPET .
- Dr. Richard Premont | Dr. GPCR Ecosystem
In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert
- Dr. Richard Premont | Dr. GPCR Ecosystem
In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert
- Dr. Richard Premont | Dr. GPCR Ecosystem
In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert
- Dr. Richard Premont | Dr. GPCR Ecosystem
In 1992, he won a Helen Hay Whitney Foundation fellowship to support his post-doctoral work with Robert
- Team Access to Terry’s Pharmacology Corner | 25% Group Discount | Dr. GPCR Ecosystem
Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge
- Yamina's Corner | Dr. GPCR Ecosystem
Core Values: The Foundation of Every Successful Partnership My advisory is built on principles that ensure As the founder of Dr.
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
Founded in 2020, Dr. Founded in 2020, Dr. What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member & Director Yamina Berchiche Get in touch Co-Founder Attila Foris Get in touch Board Member Anne M.
- FAQ | Dr. GPCR Ecosystem
These webinars are designed for scientists with foundational knowledge in receptor pharmacology, signaling
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
Science Nobody Publishes Drug discovery in the pharmaceutical industry generates enormous volumes of foundational Scientists who build careers in this space often generate more foundational knowledge than their publication
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
a high-risk research bet, the CGRP drug approvals are both a vindication and a reminder of how much foundational Hay frames this as one of the foundational unsolved problems in RAMP pharmacology: without tools to visualize
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
With a foundational career at Cisbio Bioassays—later acquired by Revvity—Eric played a pivotal role in
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
His training has provided a strong foundation and appreciation for the applications of pharmacology,
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
Jacob Lee and Jin Cho, co-founders of GeneMode, on the ten billion dollars American labs waste every In this conversation, Jacob Lee and Jin Cho — co-founders of GeneMode — describe what they saw when they About the Guests Jacob Lee is the CEO and co-founder of GeneMode. He trained as a bioengineer and worked as a research scientist in stem cell and cancer labs before founding Jin Cho is the CTO and co-founder of GeneMode.
- Eurofins DiscoverX | Dr. GPCR | Dr. GPCR Ecosystem
Eurofins Discovery Eurofins DiscoverX cell lines, assays, kits, and custom product solutions represent the foundation
























